Prof McMillan is the Director of the Molecular Disease Program at Griffith Univeristy and an internationally recognized as an expert in the area of Gene silencing therapy with major contributions over the last 10 years in the areas of delivery, virally caused cancers and the interface between RNAi and the immune system. He has published over 80 papers and books chapters and has recent papers in Clinical Cancer Research, Nature Nanotechnology and Nature Communications.